May 18, 2020
Aprea Therapeutics to Present at 2020 RBC Capital Markets Global Healthcare Conference
Media
May 15, 2020
Oncopeptides presents pre-clinical melflufen data at the AACR Annual Meeting 2020 that further validates the technical platform, PDC
May 15, 2020
Orexo´s partner Gesynta Pharma announces positive results from phase 1 study for OX-MPI
May 15, 2020
Aprea Therapeutics Reports First Quarter 2020 Financial Results and Provides Update on Business Operations
May 14, 2020
Nordic Nanovector’s Betalutin® Receives Positive Opinion for Orphan Drug Designation from EMA for Marginal Zone Lymphoma (MZL)
May 14, 2020
Oncopeptides announces new clinical and preclinical melflufen data at the upcoming European Hematology Association meeting
May 14, 2020
Targovax announces that the ONCOS-102 and durvalumab abstract is selected for a Poster Discussion Session at ASCO
May 13, 2020
Oncopeptides announces that two abstracts on multiple myeloma have been accepted by the 2020 ASCO Annual Meeting
May 12, 2020
Spruce Biosciences Announces Launch of CAHstudy.com to Initiate Screening of Patients for CAH Clinical Program
May 11, 2020
Strongbridge Biopharma plc Announces Completion of Enrollment of Phase 3 LOGICS Study for RECORLEV® (levoketoconazole) for Endogenous Cushing’s Syndrome